Analyst Upgrade Signal: INCR from Speculative Buy to Buy by Canaccord Genuity
Price Target: $13
Report Date: 05-18-2022
Symbol: INCR - InterCure Ltd.
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Analyst Upgrade Signal: INCR from Speculative Buy to Buy by Canaccord Genuity
Price Target: $13
InterCure Ltd. (INCR)
85 Medinat ha-Yehudim Street
Herzliya, 4676670
Phone: 972 7 7460 5012
Website: https://www.intercure.co
CEO:
NASDAQ, Nasdaq Global Market
InterCure Ltd, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
best stock signal alert software, free stock signal software, free stock market signals, free stock market signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228